Goldring SR, Goldring MB. Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk. Nat Rev Rheumatol. 2016;2016:632–44.
Massague J. TGFbeta signalling in context. Nat Rev Mol Cell Biol. 2012;2012:616–30.
Morikawa M, Derynck R, Miyazono K. TGF-beta and the TGFbeta family: context dependent roles in cell and tissue physiology. Cold Spring Harb Perspect Biol. 2016;2016: 8(5), a021873.
Ayyaz A, Attisano L, Wrana JL. Recent advances in understanding contextual TGFbeta signaling. F1000Res. 2017;2017:749.
Derynck R, Budi EH. Specificity, versatility, and control of TGFbeta family signaling. Sci Signal. 2019;2019: 12(570), eaav5183.
Wrana JL. Signaling by the TGFbeta superfamily. Cold Spring Harb Perspect Biol. 2013;2013:a011197.
Miyazawa K, Miyazono K. Regulation of TGF-beta family signaling by inhibitory smads. Cold Spring Harb Perspect Biol. 2016;2017: 9(3), a022095.
Cisternas MG, Murphy L, Sacks JJ, Solomon DH, Pasta DJ, Helmick CG. Alternative methods for defining osteoarthritis and the impact on estimating prevalence in a US population-based survey. Arthritis Care Res (Hoboken). 2015;2016:574–80.
Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;2012:2197–223.
van de Laar IM, Oldenburg RA, Pals G, Roos-Hesselink JW, de Graaf BM, Verhagen JM, et al. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet. 2011;2011:121–6.
van de Laar IM, van der Linde D, Oei EH, Bos PK, Bessems JH, Bierma-Zeinstra SM, et al. Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome. J Med Genet. 2011;2012:47–57.
Hopwood B, Tsykin A, Findlay DM, Fazzalari NL. Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-beta/bone morphogenic protein signalling. Arthritis Res Ther. 2007;2007:R100.
Dequeker J, Mohan S, Finkelman RD, Aerssens J, Baylink DJ. Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis. Arthritis Rheum. 1993;1993:1702–8.
Kumarasinghe DD, Perilli E, Tsangari H, Truong L, Kuliwaba JS, Hopwood B, et al. Critical molecular regulators, histomorphometric indices and their correlations in the trabecular bone in primary hip osteoarthritis. Osteoarthritis Cartilage. 2010;2010:1337–44.
Truong LH, Kuliwaba JS, Tsangari H, Fazzalari NL. Differential gene expression of bone anabolic factors and trabecular bone architectural changes in the proximal femoral shaft of primary hip osteoarthritis patients. Arthritis Res Ther. 2006;2006:R188.
Aref-Eshghi E, Liu M, Razavi-Lopez SB, Hirasawa K, Harper PE, Martin G, et al. SMAD3 is upregulated in human osteoarthritic cartilage independent of the promoter DNA methylation. J Rheumatol. 2015;2016:388–94.
Hsueh MF, Zhang X, Wellman SS, Bolognesi MP, Kraus VB. Synergistic roles of macrophages and neutrophils in osteoarthritis progression. Arthritis Rheumatol. 2020;2020.
Yao JY, Wang Y, An J, Mao CM, Hou N, Lv YX, et al. Mutation analysis of the Smad3 gene in human osteoarthritis. Eur J Hum Genet. 2003;2003:714–7.
Valdes AM, Spector TD, Tamm A, Kisand K, Doherty SA, Dennison EM, et al. Genetic variation in the SMAD3 gene is associated with hip and knee osteoarthritis. Arthritis Rheum. 2010;2010:2347–52.
Hackinger S, Trajanoska K, Styrkarsdottir U, Zengini E, Steinberg J, Ritchie GRS, et al. Evaluation of shared genetic aetiology between osteoarthritis and bone mineral density identifies SMAD3 as a novel osteoarthritis risk locus. Hum Mol Genet. 2017;2017:3850–8.
Lu C, Shu J, Han Y, Ren XY, Xu K, Fan H, et al. The polymorphism of SMAD3 rs1065080 is associated with increased risk for knee osteoarthritis. Mol Biol Rep. 2019;2019:4501–5.
Zhao T, Zhao J, Ma C, Wei J, Wei B, Liu J. Common variants in LTBP3 gene contributed to the risk of hip osteoarthritis in Han Chinese population. Biosci Rep. 2020; 2020: 40(6), BSR20192999.
•• Zengini E, Hatzikotoulas K, Tachmazidou I, Steinberg J, Hartwig FP, Southam L, et al. Genome-wide analyses using UK Biobank data provide insights into the genetic architecture of osteoarthritis. Nat Genet. 2018;2018:549–58. This study employs the UK Biobank dataset and genome-wide analyses to uncover causal variants for OA, including variants in TGFβ related genes.
•• Tachmazidou I, Hatzikotoulas K, Southam L, Esparza-Gordillo J, Haberland V, Zheng J, et al. Identification of new therapeutic targets for osteoarthritis through genome-wide analyses of UK Biobank data. Nat Genet. 2019;2019:230–6. This study leverages the UK Biobank and Arthritis Research UK Osteoarthritis Genetics resources for genome-wide association studies, identifying a single variant within the TGFB1 gene as causal for OA development.
Rys JP, Monteiro DA, Alliston T. Mechanobiology of TGFbeta signaling in the skeleton. Matrix Biol. 2016;2016:413–25.
Wipff PJ, Rifkin DB, Meister JJ, Hinz B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol. 2007;2007:1311–23.
Rys JP, DuFort CC, Monteiro DA, Baird MA, Oses-Prieto JA, Chand S, et al. Discrete spatial organization of TGFbeta receptors couples receptor multimerization and signaling to cellular tension. Elife. 2015;2015:e09300.
Monteiro DA, Dole NS, Campos JL, Kaya S, Schurman CA, Belair CD, et al. Fluid shear stress generates a unique signaling response by activating multiple TGFbeta family type I receptors in osteocytes. FASEB J. 2021;2021:e21263.
Haudenschild DR, Chen J, Pang N, Lotz MK, D’Lima DD. Rho kinase-dependent activation of SOX9 in chondrocytes. Arthritis Rheum. 2009;2010:191–200.
Allen JL, Cooke ME, Alliston T. ECM stiffness primes the TGFbeta pathway to promote chondrocyte differentiation. Mol Biol Cell. 2012;2012:3731–42.
Albro MB, Nims RJ, Cigan AD, Yeroushalmi KJ, Alliston T, Hung CT, et al. Accumulation of exogenous activated TGF-beta in the superficial zone of articular cartilage. Biophys J. 2013;2013:1794–804.
Albro MB, Cigan AD, Nims RJ, Yeroushalmi KJ, Oungoulian SR, Hung CT, et al. Shearing of synovial fluid activates latent TGF-beta. Osteoarthritis Cartilage. 2012;2012:1374–82.
Albro MB, Nims RJ, Cigan AD, Yeroushalmi KJ, Shim JJ, Hung CT, et al. Dynamic mechanical compression of devitalized articular cartilage does not activate latent TGF-beta. J Biomech. 2013;2013:1433–9.
Madej W, van Caam A, Blaney Davidson EN, van der Kraan PM, Buma P. Physiological and excessive mechanical compression of articular cartilage activates Smad2/3P signaling. Osteoarthritis Cartilage. 2014;2014:1018–25.
Madej W, van Caam A, Blaney Davidson E, Buma P, van der Kraan PM. Unloading results in rapid loss of TGFbeta signaling in articular cartilage: role of loading-induced TGFbeta signaling in maintenance of articular chondrocyte phenotype? Osteoarthritis Cartilage. 2016;2016:1807–15.
Blaney Davidson EN, Remst DF, Vitters EL, van Beuningen HM, Blom AB, Goumans MJ, et al. Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice. J Immunol. 2009;2009:7937–45.
van Caam A, Madej W, Thijssen E, Garcia de Vinuesa A, van den Berg W, Goumans MJ, et al. Expression of TGFbeta-family signalling components in ageing cartilage: age-related loss of TGFbeta and BMP receptors. Osteoarthritis Cartilage. 2016;2016:1235–45.
Madej W, van Caam A, Davidson EN, Hannink G, Buma P, van der Kraan PM. Ageing is associated with reduction of mechanically-induced activation of Smad2/3P signaling in articular cartilage. Osteoarthritis Cartilage. 2015;2016:146–57.
Zhen G, Wen C, Jia X, Li Y, Crane JL, Mears SC, et al. Inhibition of TGF-beta signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med. 2013;2013:704–12.
Bonewald LF. The amazing osteocyte. J Bone Miner Res. 2011;2011:229–38.
Dole NS, Mazur CM, Acevedo C, Lopez JP, Monteiro DA, Fowler TW, et al. Osteocyte-intrinsic TGF-beta signaling regulates bone quality through perilacunar/canalicular remodeling. Cell Rep. 2017;2017:2585–96.
Dole NS, Yee CS, Mazur CM, Acevedo C, Alliston T. TGFbeta Regulation of Perilacunar/Canalicular remodeling is sexually dimorphic. J Bone Miner Res. 2020;2020:1549–61.
• Bailey KN, Nguyen J, Yee CS, Dole NS, Dang A. Alliston T. Mechanosensitive control of articular cartilage and subchondral bone homeostasis requires osteocytic TGFbeta signaling. Arthritis Rheumatol. 2020;2021: 73(3), 414-425. This study demonstrates that osteocytic TGFβ signaling is required for articular cartilage health and the mechanosensitive response to joint injury.
Scharstuhl A, Glansbeek HL, van Beuningen HM, Vitters EL, van der Kraan PM, van den Berg WB. Inhibition of endogenous TGF-beta during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair. J Immunol. 2002;2002:507–14.
Kumarasinghe DD, Sullivan T, Kuliwaba JS, Fazzalari NL, Atkins GJ. Evidence for the dysregulated expression of TWIST1, TGFbeta1 and SMAD3 in differentiating osteoblasts from primary hip osteoarthritis patients. Osteoarthritis Cartilage. 2012;2012:1357–66.
Massicotte F, Lajeunesse D, Benderdour M, Pelletier JP, Hilal G, Duval N, et al. Can altered production of interleukin-1beta, interleukin-6, transforming growth factor-beta and prostaglandin E(2) by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. Osteoarthritis Cartilage. 2002;2002:491–500.
Couchourel D, Aubry I, Delalandre A, Lavigne M, Martel-Pelletier J, Pelletier JP, et al. Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production. Arthritis Rheum. 2009;2009:1438–50.
Chan TF, Couchourel D, Abed E, Delalandre A, Duval N, Lajeunesse D. Elevated Dickkopf-2 levels contribute to the abnormal phenotype of human osteoarthritic osteoblasts. J Bone Miner Res. 2011;2011:1399–410.
Abed E, Bouvard B, Martineau X, Jouzeau JY, Reboul P, Lajeunesse D. Elevated hepatocyte growth factor levels in osteoarthritis osteoblasts contribute to their altered response to bone morphogenetic protein-2 and reduced mineralization capacity. Bone. 2015;2015:111–9.
Kang JS, Alliston T, Delston R, Derynck R. Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. EMBO J. 2005;2005:2543–55.
• Mazur CM, Woo JJ, Yee CS, Fields AJ, Acevedo C, Bailey KN, et al. Osteocyte dysfunction promotes osteoarthritis through MMP13-dependent suppression of subchondral bone homeostasis. Bone Res. 2019;2019:34 This study demonstrates a causal role for osteocytes in osteoarthritis.
Tang SY, Alliston T. Regulation of postnatal bone homeostasis by TGFbeta. Bonekey Rep. 2014;2013:255.
Kaneda T, Nojima T, Nakagawa M, Ogasawara A, Kaneko H, Sato T, et al. Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor. J Immunol. 2000;2000:4254–63.
Oursler MJ. Osteoclast synthesis and secretion and activation of latent transforming growth factor beta. J Bone Miner Res. 1994;1994:443–52.
Fuller K, Lean JM, Bayley KE, Wani MR, Chambers TJ. A role for TGFbeta(1) in osteoclast differentiation and survival. J Cell Sci. 2000;2000:2445–53.
Hayami T, Pickarski M, Wesolowski GA, McLane J, Bone A, Destefano J, et al. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum. 2004;2004:1193–206.
留言 (0)